Objective of the study is to measure the effects of long term fluoxetine administration on brain- and muscle activity in combination with the effects on motor function. Main questions are:(1) Influences long-term administration of fluoxetine…
ID
Source
Brief title
Condition
- Central nervous system vascular disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
Primary study parameters are:
- Motor threshold (MT) to measure excitability
- stimulus response curve (SRC) to measure excitability
- root mean square (RMS) of the electromyogram (EMG) of the lower part of the
arm, to measure muscle activation.
Secondary outcome
Secundary study paramters are:
- activation of frequencybands in the brain;
- phase-synchronization in the brain, to measure communication between
different areas;
- motor function.
Background summary
Stroke is one of the major causes of disability in developed countries. After
stroke most patients suffer from hemiparesis, and mainly the distal parts of
the body are affected. Even after intensive training many patients still suffer
from motor impairment. One
Previous studies have been done examining the effects of neuropharmaca on motor
recovery.
One neuropharmaca of which the effect is studied before are selective serotonin
reuptake inhibitors (SSRIs). However, inconsistent results were found, as some
studies found an improved motor function, while other studies did not found any
effects. These studies only measured motor function.
While several fundamental variables are correlated with a changed motor
function, this study examines the effects of fluoxetine (SSRI) on these
variables and relates these changes to motor function. This will possibly
explain why fluoxetine could improve motor function. Hypotheses are: (1)
Long-term use of fluoxetine causes the excitability of the primary motor area
of the brain to change; (2) Long-term administration of fluoxetine causes the
muscle activation patterns to increase; (3)Long-term use of fluoxetine
modulates activation of areas in the brain during voluntary movement; (4)
Long-term administration of lfuoxetine increase the communication between areas
of the brain; (5) Long-term administration of fluoxetine causes the motor
function to change.
Study objective
Objective of the study is to measure the effects of long term fluoxetine
administration on brain- and muscle activity in combination with the effects on
motor function.
Main questions are:
(1) Influences long-term administration of fluoxetine excitability of the
primary motor cortex of the brain?
(2) Does long-term administration of fluoxetine increase the muscle activation
patterns?
Secondary questions are:
(3) Influences long term administration of fluoxetine activity patterns in the
brain?
(4) Does communication between areas in the brain improve after long term
administration of fluoxetine?
(5) Does motor function improve after long term administration of fluoxetine?
Study design
Doubleblind placebo controlled study
Intervention
17 Patients have to administer one tablet containing 20 mg of fluoxetine every
day during 12 weeks. The other 17 patients receive one tablet of placebo every
day.
Study burden and risks
Therapeutic risks of the current study, are the side effects of fluoxetine.
These side effects are mostly nausea and restlessness. However some harsh side
effects, like serotoninesyndrom, occur rarely. All reported side effects are
mentioned in the IB.
Non-therapeutic risk comes from the use of transcranial magnetic stimulation
(TMS) which is used to measure brain excitability. A rarely occuring side
effect is the activation of an epileptic insult.
Haaksbergerstraat 55
7513 ER Enschede
NL
Haaksbergerstraat 55
7513 ER Enschede
NL
Listed location countries
Age
Inclusion criteria
First ever ischemic cortical/subcortical ischemic stroke, confirmed by CT or MRI; more than 6 months after stroke; age > 18
Exclusion criteria
Patients suffering from another neurological disease; uncompensated hemineglect or cognitive disabilities; epilepsy, or first epileptic insult post stroke; patients with first grade relatives suffering from epilepsy; pregnancy; pacemaker; pathological heart rhythms disorders; use of antidepressants.
Design
Recruitment
Medical products/devices used
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
EudraCT | EUCTR2006-005044-86-NL |
CCMO | NL14459.044.06 |